{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:42:02Z","timestamp":1793040122904,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14409-1","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:36:34Z","timestamp":1774690594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness studies evaluating HPV self-sampling for cervical cancer screening \u2013 a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"L\u00e1ra R.","family":"Hallsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Hoflacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stratil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Muehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hillemanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jentschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Sroczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"3","key":"14409_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics, 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"14409_CR2","unstructured":"Global cancer observatory: Cancer Today (version 1.1) https:\/\/gco.iarc.who.int\/today."},{"issue":"10071","key":"14409_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP, Vanderpuye E V, Kotha A, Sarker SR, et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847\u201360.","journal-title":"Lancet"},{"key":"14409_CR4","unstructured":"IARC. IARC Handbooks of Cancer Prevention Cervical Cancer Screening. Vol. 18. Lyon, France: IARC Press; 2022."},{"key":"14409_CR5","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: cC BY-NC-SA 3.0 IGO."},{"key":"14409_CR6","unstructured":"Health at a Glance 2023: OECD indicators cancer screening https:\/\/www.oecd-ilibrary.org\/sites\/7dbf67b5-en\/index.html?itemId=\/content\/component\/7dbf67b5-en."},{"issue":"7","key":"14409_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2018.10400","volume":"320","author":"J Melnikow","year":"2018","unstructured":"Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(7):687\u2013705.","journal-title":"JAMA"},{"key":"14409_CR8","doi-asserted-by":"crossref","unstructured":"Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Global Health. 2015;3(2):e85\u201394.","DOI":"10.1016\/S2214-109X(14)70354-7"},{"issue":"1","key":"14409_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcv.2013.06.029","volume":"58","author":"L Darlin","year":"2013","unstructured":"Darlin L, Borgfeldt C, Forslund O, H\u00e9nic E, Hortlund M, Dillner J, et al. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol. 2013;58(1):155\u201360.","journal-title":"J Clin Virol"},{"issue":"6","key":"14409_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","volume":"104","author":"A Szarewski","year":"2011","unstructured":"Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening: a randomised controlled trial. Br J Cancer. 2011;104(6):915\u201320.","journal-title":"Br J Cancer"},{"key":"14409_CR11","doi-asserted-by":"crossref","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k 4823.","DOI":"10.1136\/bmj.k4823"},{"issue":"16","key":"14409_CR12","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375\u201385.","journal-title":"Eur J Cancer"},{"issue":"3","key":"14409_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10198-003-0205-2","volume":"4","author":"U Siebert","year":"2003","unstructured":"Siebert U. When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ: HEPAC. 2003;4(3):143\u201350.","journal-title":"Eur J Health Econ Former: HEPAC"},{"key":"14409_CR14","volume-title":"Methods for the economic Evaluation of Health care programmes","author":"M Drummond","year":"2015","unstructured":"Drummond M. Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford University Press; 2015."},{"issue":"5","key":"14409_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0272989X12454577","volume":"32","author":"JJ Caro","year":"2012","unstructured":"Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices-overview: a report of the ISPOR-SMDM modeling Good Research Practices Task Force-1. Med Decis Making. 2012;32(5):667\u201377.","journal-title":"Med Decis Mak"},{"issue":"6","key":"14409_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jval.2012.06.016","volume":"15","author":"M Roberts","year":"2012","unstructured":"Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2. Value Health. 2012;15(6):804\u201311.","journal-title":"Value Health"},{"issue":"5","key":"14409_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0272989X12455463","volume":"32","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Med Decis Mak. 2012;32(5):690\u2013700.","journal-title":"Med Decis Mak"},{"issue":"1","key":"14409_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1332\/174426410X482999","volume":"6","author":"I Shemilt","year":"2010","unstructured":"Shemilt I, James T, Marcello M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6(1):51\u201359.","journal-title":"Evid Policy"},{"key":"14409_CR19","unstructured":"World Economic Outlook Database. 2023, Oct; https:\/\/www.imf.org\/en\/Publications\/WEO\/weo-database\/2023\/October."},{"issue":"5","key":"14409_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/cer.15.38","volume":"4","author":"R Schwarzer","year":"2015","unstructured":"Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, et al. Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J Comp Eff Res. 2015;4(5):485\u2013504.","journal-title":"J Comp Eff Res"},{"key":"14409_CR21","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"4","key":"14409_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jval.2021.01.002","volume":"24","author":"O Mandrik","year":"2021","unstructured":"Mandrik O, Severens JL, Bardach A, Ghabri S, Hamel C, Mathes T, et al. Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report. Value Health. 2021;24(4):463\u201372.","journal-title":"Value Health"},{"issue":"3","key":"14409_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/1471-0528.17012","volume":"129","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, Briggs AH, Carswell C, Caulley L, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. 2022;129(3):336\u201344.","journal-title":"Bjog"},{"issue":"1","key":"14409_CR24","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1186\/s12889-023-17358-0","volume":"23","author":"C Kositamongkol","year":"2023","unstructured":"Kositamongkol C, Kanchanasurakit S, Mepramoon E, Talungchit P, Chaopotong P, Kengkla K, et al. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand. BMC Public Health. 2023;23(1):2413.","journal-title":"BMC Public Health"},{"issue":"1","key":"14409_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12916-023-02840-8","volume":"21","author":"XL Zhao","year":"2023","unstructured":"Zhao XL, Zhao S, Xia CF, Hu SY, Duan XZ, Liu ZH, et al. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study. BMC Med. 2023;21(1):149.","journal-title":"BMC Med"},{"issue":"3","key":"14409_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ijc.33850","volume":"150","author":"K Pedersen","year":"2022","unstructured":"Pedersen K, Portnoy A, Sy S, Hansen BT, Trop\u00e9 A, Kim JJ, et al. Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: a cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women. Int J Cancer. 2022;150(3):491\u2013501.","journal-title":"Int. J Cancer"},{"issue":"3","key":"14409_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/LGT.0b013e3181cd6d36","volume":"14","author":"A Balasubramanian","year":"2010","unstructured":"Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis. 2010;14(3):185\u201395.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"14409_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1055-9965.EPI-16-0350","volume":"26","author":"EA Burger","year":"2017","unstructured":"Burger EA, Sy S, Nyg\u00e5rd M, Kim JJ. The cost-effectiveness of cervical self-sampling to improve routine cervical cancer screening: the importance of respondent screening history and compliance. Cancer Epidemiol Biomarker Prev. 2017;26(1):95\u2013103.","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"5","key":"14409_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.EPI-14-0998","volume":"24","author":"K Rozemeijer","year":"2015","unstructured":"Rozemeijer K, de Kok IMCM, Naber SK, van Kemenade FJ, Penning C, van Rosmalen J, et al. Offering self-sampling to non-attendees of organized primary HPV screening: When do harms outweigh the benefits? Cancer Epidemiol Biomarker Prev. 2015;24(5):773\u201382.","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"1","key":"14409_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ygyno.2019.01.021","volume":"153","author":"P Vassilakos","year":"2019","unstructured":"Vassilakos P, Poncet A, Catarino R, Viviano M, Petignat P, Combescure C. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland. Gynecol Oncol. 2019;153(1):92\u201399.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"14409_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0969141317704679","volume":"25","author":"A Tsiachristas","year":"2018","unstructured":"Tsiachristas A, Gittins M, Kitchener H, Gray A. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC). J Med Screen. 2018;25(2):99\u2013109.","journal-title":"J Med Screen"},{"issue":"68","key":"14409_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20680","volume":"20","author":"HC Kitchener","year":"2016","unstructured":"Kitchener HC, Gittins M, Rivero-Arias O, Tsiachristas A, Cruickshank M, Gray A, et al. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC). Health Technol Assess. 2016;20(68):1\u2013138.","journal-title":"Health Technol Assess"},{"issue":"2","key":"14409_CR33","first-page":"261","volume":"22","author":"YN Flores","year":"2011","unstructured":"Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hern\u00e1ndez M, et al. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control. 2011;22(2):261\u201372.","journal-title":"Cancer Causes Control"},{"issue":"12","key":"14409_CR34","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.33759","volume":"149","author":"A Keane","year":"2021","unstructured":"Keane A, Ng CW, Simms KT, Nguyen D, Woo YL, Saville M, et al. The road to cervical cancer elimination in Malaysia: evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support. Int J Cancer. 2021;149(12):1997\u20132009.","journal-title":"Int. J Cancer"},{"issue":"1","key":"14409_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s12885-020-07085-9","volume":"20","author":"R Aarnio","year":"2020","unstructured":"Aarnio R, \u00d6stensson E, Olovsson M, Gustavsson I, Gyllensten U. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study. BMC Cancer. 2020;20(1):645.","journal-title":"BMC Cancer"},{"key":"14409_CR36","doi-asserted-by":"crossref","unstructured":"Wong EL, Chan PK, Chor JS, Cheung AW, Huang F, Wong SY. Evaluation of the impact of human papillomavirus DNA self-sampling on the uptake of cervical cancer screening. Cancer Nurs. 2016;39(1):E1\u2013E11.","DOI":"10.1097\/NCC.0000000000000241"},{"key":"14409_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ygyno.2022.10.027","volume":"168","author":"T Knauss","year":"2023","unstructured":"Knauss T, Hansen BT, Pedersen K, Aasb\u00f8 G, Kunst N, Burger EA. The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: the Equalscreen randomized controlled trial. Gynecol Oncol. 2023;168:39\u201347.","journal-title":"Gynecologic Oncol"},{"key":"14409_CR38","doi-asserted-by":"crossref","unstructured":"Meenan RT, Troja C, Buist DSM, Tiro JA, Lin J, Anderson ML, et al. Economic evaluation of mailed home-based human papillomavirus self-sampling kits for cervical cancer screening. JAMA Netw Open. 2023;6(3):e234052.","DOI":"10.1001\/jamanetworkopen.2023.4052"},{"issue":"8","key":"14409_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1158\/1055-9965.EPI-22-1267","volume":"32","author":"LP Spees","year":"2023","unstructured":"Spees LP, Biddell CB, Smith JS, Des Marais AC, Hudgens MG, Sanusi B, et al. Cost-effectiveness of human papillomavirus self-collection intervention on cervical cancer screening uptake among underscreened U.S. persons with a cervix. Cancer Epidemiol Biomarker Prev. 2023;32(8):1097\u2013106.","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"6","key":"14409_CR40","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1158\/1055-9965.EPI-20-1673","volume":"30","author":"NG Campos","year":"2021","unstructured":"Campos NG, Scarinci IC, Tucker L, Peral S, Li Y, Regan MC, et al. Cost-effectiveness of offering cervical cancer screening with HPV self-sampling among African-American women in the Mississippi Delta. Cancer Epidemiol Biomarker Prev. 2021;30(6):1114\u201321.","journal-title":"Cancer Epidemiol Biomarker Prev"},{"key":"14409_CR41","doi-asserted-by":"publisher","first-page":"105931","DOI":"10.1016\/j.ypmed.2019.105931","volume":"131","author":"NG Campos","year":"2020","unstructured":"Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, et al. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med. 2020;131:105931.","journal-title":"Prev Med"},{"issue":"11","key":"14409_CR42","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/bjc.2014.510","volume":"111","author":"K Haguenoer","year":"2014","unstructured":"Haguenoer K, Sengchanh S, Gaudy-Graffin C, Boyard J, Fontenay R, Marret H, et al. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer. 2014;111(11):2187\u201396.","journal-title":"Br J Cancer"},{"issue":"7","key":"14409_CR43","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/aogs.12143","volume":"92","author":"E \u00d6stensson","year":"2013","unstructured":"\u00d6stensson E, Hellstr\u00f6m A-C, Hellman K, Gustavsson I, Gyllensten U, Wilander E, et al. Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program. Acta Obstet Gynecol Scand. 2013;92(7):830\u201340.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"14409_CR44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.22484","volume":"120","author":"AG Bais","year":"2007","unstructured":"Bais AG, van Kemenade FJ, Berkhof J, Verheijen RHM, Snijders PJF, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120(7):1505\u201310.","journal-title":"Int J Cancer"},{"issue":"10","key":"14409_CR45","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1089\/jwh.2021.0597","volume":"31","author":"J Boyard","year":"2022","unstructured":"Boyard J, Caille A, Brunet-Houdard S, Sengchanh-Vidal S, Giraudeau B, Marret H, et al. A home-mailed versus general practitioner-delivered vaginal self-sampling kit for cervical cancer screening: a cluster randomized controlled trial with a cost-effectiveness analysis. J Womens Health (Larchmt). 2022;31(10):1472\u201380.","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"14409_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12905-015-0261-7","volume":"15","author":"A Virtanen","year":"2015","unstructured":"Virtanen A, Anttila A, Nieminen P. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland. BMC Womens Health. 2015;15(1):99.","journal-title":"BMC Womens Health"},{"issue":"12","key":"14409_CR47","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jfma.2015.10.014","volume":"115","author":"HH Chou","year":"2016","unstructured":"Chou HH, Huang HJ, Cheng HH, Chang CJ, Yang LY, Huang CC, et al. Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan. J Formos Med Assoc. 2016;115(12):1089\u201396.","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"14409_CR48","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.28545","volume":"134","author":"G Broberg","year":"2014","unstructured":"Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd ML, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer. 2014;134(9):2223\u201330.","journal-title":"Int. J Cancer"},{"issue":"4","key":"14409_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/070674370805300408","volume":"53","author":"JS Hoch","year":"2008","unstructured":"Hoch JS, Dewa CS. A clinician\u2019s guide to correct cost-effectiveness analysis: think incremental not average. Can J Psychiatry. 2008;53(4):267\u201374.","journal-title":"Can J Psychiatry"},{"key":"14409_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"M Gold","year":"1996","unstructured":"Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996."},{"key":"14409_CR51","doi-asserted-by":"publisher","first-page":"105953","DOI":"10.1016\/j.ypmed.2019.105953","volume":"132","author":"C Malone","year":"2020","unstructured":"Malone C, Barnabas RV, Buist DSM, Tiro JA, Winer RL. Cost-effectiveness studies of HPV self-sampling: a systematic review. Prev Med. 2020;132:105953.","journal-title":"Prev Med"},{"issue":"5","key":"14409_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41416-022-02094-w","volume":"128","author":"S Costa","year":"2023","unstructured":"Costa S, Verberckmoes B, Castle PE, Arbyn M. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br J Cancer. 2023;128(5):805\u201313.","journal-title":"Br J Cancer"},{"key":"14409_CR53","doi-asserted-by":"crossref","unstructured":"Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):CD008587.","DOI":"10.1002\/14651858.CD008587.pub2"},{"issue":"1","key":"14409_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.34358","volume":"153","author":"M Rebolj","year":"2023","unstructured":"Rebolj M, Sargent A, Njor SH, Cuschieri K. Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: make haste slowly. Int J Cancer. 2023;153(1):8\u201319.","journal-title":"Int. J Cancer"},{"key":"14409_CR55","doi-asserted-by":"publisher","first-page":"107096","DOI":"10.1016\/j.ypmed.2022.107096","volume":"160","author":"DM Ejegod","year":"2022","unstructured":"Ejegod DM, Pedersen H, Pedersen BT, Serizawa R, Bonde J. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders. Prev Med. 2022;160:107096.","journal-title":"Prev Med"},{"key":"14409_CR56","doi-asserted-by":"crossref","unstructured":"Elfstr\u00f6m M, Gray PG, Dillner J. Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic. eLife. 2023;12.","DOI":"10.7554\/eLife.80905"},{"key":"14409_CR57","doi-asserted-by":"crossref","unstructured":"G\u00f6k M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:c 1040.","DOI":"10.1136\/bmj.c1040"},{"issue":"1","key":"14409_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","volume":"17","author":"CA Aitken","year":"2019","unstructured":"Aitken CA, van Agt HME, Siebers AG, van Kemenade FJ, Niesters HGM, Melchers WJG, et al. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study. BMC Med. 2019;17(1):228.","journal-title":"BMC Med"},{"issue":"1","key":"14409_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13690-021-00667-4","volume":"79","author":"H De Pauw","year":"2021","unstructured":"De Pauw H, Donders G, Weyers S, De Sutter P, Doyen J, Tjalma WAA, et al. Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study. Arch Public Health. 2021;79(1):155.","journal-title":"Arch Public Health"},{"key":"14409_CR60","doi-asserted-by":"crossref","unstructured":"Marlow L, Drysdale H, Waller J. Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: a cross-sectional survey of women taking part in a clinical validation of HPV self-collection devices. J Med Screen. 2024;9691413241283356.","DOI":"10.1177\/09691413241283356"},{"key":"14409_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","volume":"125","author":"NJ Polman","year":"2019","unstructured":"Polman NJ, de Haan Y, Veldhuijzen NJ, Heideman DAM, de Vet HCW, Meijer C, et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med. 2019;125:5\u201311.","journal-title":"Prev Med"},{"issue":"5","key":"14409_CR62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1158\/1940-6207.CAPR-19-0506","volume":"13","author":"G Sroczynski","year":"2020","unstructured":"Sroczynski G, Gogollari A, Kuehne F, Hallsson LR, Widschwendter M, Pashayan N, et al. A systematic review on cost-effectiveness studies evaluating ovarian cancer early detection and prevention strategies. Cancer Prev Res (Phila). 2020;13(5):429\u201342.","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14409-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:04:35Z","timestamp":1778141075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14409"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14409-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"654"}}